Monogram Health, a Nashville, Tenn.-based kidney disease care management company, secured $7m in funding through the closing of a Series A-1 financing round.
The round was co-led by Frist Cressey Ventures and Norwest Venture Partners.
The company intends to use the funds to continue to grow and increase health plan partnerships.
Monogram Health is a renal disease care management company providing partnering with health plans through a national network of nephrologists and kidney care specialists. Through these regular visits, its specialized care teams monitor and manage patients’ kidney care delivery, such as appropriate medication compliance, as well as transitions to and adherence with renal replacement, palliative care, and other evidence-based treatment modalities.
Monogram currently operates its kidney disease care management programs for thousands of patients across the U.S., including Humana Medicare Advantage and Commercial plan members in Louisiana and Mississippi.